2026 Pricing Guide
Industry
Data last verified: January 2026
Vulnerability Assessment for Pharmaceutical & Life Sciences Companies
Pharmaceutical & life sciences companies typically invest $3K-$14K in vulnerability assessment. Get quotes from vetted providers in 24 hours.
$3K-$14K
Adjusted for pharmaceutical & life sciences industry
Pricing verified Q1 202645+ vendor interviews127+ data sourcesUpdated monthly
Vulnerability Assessment for Pharmaceutical & Life Sciences
Pharmaceutical companies and biotech firms
Avg Security Budget
$150,000-$1,000,000
Security Maturity
high
Price Multiplier
1.4x baseline
Why Pharmaceutical & Life Sciences Companies Buy Vuln Scan
Clinical trial data protection
IP theft prevention
FDA validation requirements
Research data integrity
Frequently Asked Questions
Vulnerability Assessment typically costs $2K-$10K depending on scope and complexity. For pharmaceutical & life sciences companies, expect to pay $3K-$14K due to FDA 21 CFR Part 11 and HIPAA requirements.
Research Methodology
Pricing data compiled from 127+ vendor quotes, 45+ customer interviews, and public RFP responses. Reviewed by security industry experts with 20+ years combined experience.
Last verified: January 2026 • Next update: April 2026
Ready to Get Vuln Scan Quotes for Your Pharmaceutical & Life Sciences Company?
Get matched with vendors experienced in pharmaceutical & life sciences and receive competitive quotes within 24 hours.
Get Quotes Now